SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Sclerosteosis is an autosomal recessive disease that is characterized by overgrowth of bone tissue and is linked to mutations in the gene encoding the secreted protein SOST. Sclerosteosis shares remarkable similarities with "high bone mass" diseases caused by "gain-of-function" mutations in the LRP5 gene, which encodes a coreceptor for Wnt signaling proteins. We show here that SOST antagonizes Wnt signaling in Xenopus embryos and mammalian cells by binding to the extracellular domain of the Wnt coreceptors LRP5 and LRP6 and disrupting Wnt-induced Frizzled-LRP complex formation. Our findings suggest that SOST is an antagonist for Wnt signaling and that the loss of SOST function likely leads to the hyperactivation of Wnt signaling that underlies bone overgrowth seen in sclerosteosis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The SOST protein can also bind to LRP5/6 where it can antagonize Wnt signaling.25”
From Wnt signal transduction pathways (2008) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Little, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
LDL-receptor-related proteins in Wnt signal transduction
Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J.-P., & He, X. (2000) · Nature · doi:10.1038/35035117 · Cited by 1,128
Self-citationOsteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,112
An LDL-receptor-related protein mediates Wnt signalling in mice
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., & Skarnes, W. C. (2000) · Nature · doi:10.1038/35035124 · Cited by 1,086
Cited by
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Self-citationWnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
Cosman, F., Crittenden, D. B., Adachi, J. D., Binkley, N., Czerwinski, E., Ferrari, S., Hofbauer, L. C., Lau, E., Lewiecki, E. M., Miyauchi, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607948 · Cited by 1,805
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Wnt signal transduction pathways
Komiya, Y., & Habas, R. (2008) · Organogenesis · doi:10.4161/org.4.2.5851 · Cited by 1,528
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
Robling, A. G., Niziolek, P. J., Baldridge, L. A., Condon, K. W., Allen, M. R., Alam, I., Mantila, S. M., Gluhak-Heinrich, J., Bellido, T. M., Harris, S. E., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705092200 · Cited by 1,350
Sambrook, P., & Cooper, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68891-0 · Cited by 1,165
Building strong bones: molecular regulation of the osteoblast lineage
Long, F. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3254 · Cited by 1,141
Skeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Schett, G., & Gravallese, E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.153 · Cited by 947
Li, X., Ominsky, M. S., Niu, Q.-T., Sun, N., Daugherty, B., D'Agostin, D., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 936
Structural Basis of Wnt Recognition by Frizzled
Janda, C. Y., Waghray, D., Levin, A. M., Thomas, C., & Garcia, K. C. (2012) · Science · doi:10.1126/science.1222879 · Cited by 875
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
Padhi, D., Jang, G., Stouch, B., Fang, L., & Posvar, E. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.173 · Cited by 786
Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784
Wnt/β-catenin signaling in cancers and targeted therapies
Yu, F., Yu, C., Li, F., Zuo, Y., Wang, Y., Yao, L., Wu, C., Wang, C., & Ye, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00701-5 · Cited by 734
Signaling and transcriptional regulation in osteoblast commitment and differentiation
Huang, W. (2007) · Frontiers in Bioscience · doi:10.2741/2296 · Cited by 649
Secreted and transmembrane wnt inhibitors and activators
Cruciat, C.-M., & Niehrs, C. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015081 · Cited by 646
Lin, C., Jiang, X., Dai, Z., Guo, X., Weng, T., Wang, J., Li, Y., Feng, G., Gao, X., & He, L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090411 · Cited by 628
The cell biology of bone metabolism
Datta, H. K., Ng, W. F., Walker, J. A., Tuck, S. P., & Varanasi, S. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048868 · Cited by 614
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xu, X., Zhang, M., Xu, F., & Jiang, S. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01276-5 · Cited by 588
Targeting the Wnt/β-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton
Baron, R., & Rawadi, G. (2007) · Endocrinology · doi:10.1210/en.2007-0270 · Cited by 584
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Silva, B. C., & Bilezikian, J. P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.03.005 · Cited by 557
Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 Signal
Fuentealba, L. C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E. M., & De Robertis, E. M. (2007) · Cell · doi:10.1016/j.cell.2007.09.027 · Cited by 554
Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass
Morvan, F., Boulukos, K., Clément-Lacroix, P., Roman, S. R., Suc-Royer, I., Vayssière, B., Ammann, P., Martin, P., Pinho, S., Pognonec, P., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060311 · Cited by 524
Molecular mechanosensors in osteocytes
Qin, L., Liu, W., Cao, H., & Xiao, G. (2020) · Bone Research · doi:10.1038/s41413-020-0099-y · Cited by 484
The Wnt Pathway: From Signaling Mechanisms to Synthetic Modulators
Rim, E. Y., Clevers, H., & Nusse, R. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-103615 · Cited by 483
Zhu, S., Chen, W., Masson, A., & Li, Y.-P. (2024) · Cell Discovery · doi:10.1038/s41421-024-00689-6 · Cited by 463
Mechanical Signaling for Bone Modeling and Remodeling
Robling, A. G., & Turner, C. H. (2009) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i4.50 · Cited by 422
Wnt signaling controls the fate of mesenchymal stem cells
Ling, L., Nurcombe, V., & Cool, S. M. (2009) · Gene · doi:10.1016/j.gene.2008.12.008 · Cited by 417
Osteocytes as Dynamic Multifunctional Cells
BONEWALD, L. F. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.018 · Cited by 417
Transforming growth factor‐β in stem cells and tissue homeostasis
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018) · Bone Research · doi:10.1038/s41413-017-0005-4 · Cited by 414
Osteoblast and osteocyte: Games without frontiers
Capulli, M., Paone, R., & Rucci, N. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.05.003 · Cited by 413
The role of Dickkopf-1 in bone development, homeostasis, and disease
Pinzone, J. J., Hall, B. M., Thudi, N. K., Vonau, M., Qiang, Y.-W., Rosol, T. J., & Shaughnessy, J. D. (2009) · Blood · doi:10.1182/blood-2008-03-145169 · Cited by 408
Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
Ke, H. Z., Richards, W. G., Li, X., & Ominsky, M. S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1060 · Cited by 402
Relation of age, gender, and bone mass to circulating sclerostin levels in women and men
Mödder, U. I., Hoey, K. A., Amin, S., McCready, L. K., Achenbach, S. J., Riggs, B. L., Melton, L. J., & Khosla, S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.217 · Cited by 397
Update on Wnt signaling in bone cell biology and bone disease
Monroe, D. G., McGee-Lawrence, M. E., Oursler, M. J., & Westendorf, J. J. (2012) · Gene · doi:10.1016/j.gene.2011.10.044 · Cited by 392
Muscle and bone, two interconnected tissues
Tagliaferri, C., Wittrant, Y., Davicco, M.-J., Walrand, S., & Coxam, V. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.03.002 · Cited by 390
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
O'Brien, C. A., Plotkin, L. I., Galli, C., Goellner, J. J., Gortazar, A. R., Allen, M. R., Robling, A. G., Bouxsein, M., Schipani, E., Turner, C. H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002942 · Cited by 390
Genetic regulation of bone mass and susceptibility to osteoporosis
Ralston, S. H., & de Crombrugghe, B. (2006) · Genes & Development · doi:10.1101/gad.1449506 · Cited by 364
Wnt signaling in adult intestinal stem cells and cancer
Krausova, M., & Korinek, V. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.032 · Cited by 361
Wnt signaling in bone formation and its therapeutic potential for bone diseases
Kim, J. H., Liu, X., Wang, J., Chen, X., Zhang, H., Kim, S. H., Cui, J., Li, R., Zhang, W., Kong, Y., et al. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12466608 · Cited by 356
Ellies, D. L., Viviano, B., McCarthy, J., Rey, J.-P., Itasaki, N., Saunders, S., & Krumlauf, R. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060810 · Cited by 350
Sclerostin: Current Knowledge and Future Perspectives
Moester, M. J. C., Papapoulos, S. E., Löwik, C. W. G. M., & van Bezooijen, R. L. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9372-1 · Cited by 332
Appel, H., Ruiz‐Heiland, G., Listing, J., Zwerina, J., Herrmann, M., Mueller, R., Haibel, H., Baraliakos, X., Hempfing, A., Rudwaleit, M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24888 · Cited by 326
A Wnt canon orchestrating osteoblastogenesis
Hartmann, C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.01.001 · Cited by 314
Mirza, F. S., Padhi, I. D., Raisz, L. G., & Lorenzo, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2283 · Cited by 311
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Leupin, O., Piters, E., Halleux, C., Hu, S., Kramer, I., Morvan, F., Bouwmeester, T., Schirle, M., Bueno-Lozano, M., Ramos Fuentes, F. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190330 · Cited by 301
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00028-6 · Cited by 298
Wnt signaling and cellular metabolism in osteoblasts
Karner, C. M., & Long, F. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2425-5 · Cited by 295
Pez, F., Lopez, A., Kim, M., Wands, J. R., Caron de Fromentel, C., & Merle, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.001 · Cited by 294
The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro
Spatz, J. M., Wein, M. N., Gooi, J. H., Qu, Y., Garr, J. L., Liu, S., Barry, K. J., Uda, Y., Lai, F., Dedic, C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628313 · Cited by 290
A look behind the scenes: the risk and pathogenesis of primary osteoporosis
Hendrickx, G., Boudin, E., & Van Hul, W. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.48 · Cited by 285
van Bezooijen, R. L., Svensson, J. P., Eefting, D., Visser, A., van der Horst, G., Karperien, M., Quax, P. H., Vrieling, H., Papapoulos, S. E., ten Dijke, P., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061002 · Cited by 283
Multiplicity of the interactions of Wnt proteins and their receptors
Kikuchi, A., Yamamoto, H., & Kishida, S. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.11.001 · Cited by 283
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Xue, C., Chu, Q., Shi, Q., Zeng, Y., Lu, J., & Li, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02142-w · Cited by 281
Kamiya, N., Ye, L., Kobayashi, T., Mochida, Y., Yamauchi, M., Kronenberg, H. M., Feng, J. Q., & Mishina, Y. (2008) · Development · doi:10.1242/dev.025825 · Cited by 275
Armstrong, V. J., Muzylak, M., Sunters, A., Zaman, G., Saxon, L. K., Price, J. S., & Lanyon, L. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703224200 · Cited by 273
The impact of microgravity on bone in humans
Grimm, D., Grosse, J., Wehland, M., Mann, V., Reseland, J. E., Sundaresan, A., & Corydon, T. J. (2016) · Bone · doi:10.1016/j.bone.2015.12.057 · Cited by 272
New Insights into the Mechanism of Wnt Signaling Pathway Activation
(2011) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-386035-4.00002-1 · Cited by 260
Mohammed, M. K., Shao, C., Wang, J., Wei, Q., Wang, X., Collier, Z., Tang, S., Liu, H., Zhang, F., Huang, J., et al. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2015.12.004 · Cited by 259
The Regulation of Valvular and Vascular Sclerosis by Osteogenic Morphogens
Boström, K. I., Rajamannan, N. M., & Towler, D. A. (2011) · Circulation Research · doi:10.1161/circresaha.110.234278 · Cited by 257
Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
Drake, M. T., Srinivasan, B., Mödder, U. I., Peterson, J. M., McCready, L. K., Riggs, B. L., Dwyer, D., Stolina, M., Kostenuik, P., & Khosla, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0720 · Cited by 251
Wnt and the Wnt signaling pathway in bone development and disease
Wang, Y. (2014) · Frontiers in Bioscience · doi:10.2741/4214 · Cited by 248
Qiang, Y.-W., Chen, Y., Stephens, O., Brown, N., Chen, B., Epstein, J., Barlogie, B., & Shaughnessy, J. D. (2008) · Blood · doi:10.1182/blood-2008-01-132134 · Cited by 248
Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice
Kramer, I., Loots, G. G., Studer, A., Keller, H., & Kneissel, M. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090730 · Cited by 247
Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors
Leupin, O., Kramer, I., Collette, N. M., Loots, G. G., Natt, F., Kneissel, M., & Keller, H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070804 · Cited by 246
Selective activation mechanisms of Wnt signaling pathways
Kikuchi, A., Yamamoto, H., & Sato, A. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.01.003 · Cited by 244
Moustafa, A., Sugiyama, T., Prasad, J., Zaman, G., Gross, T. S., Lanyon, L. E., & Price, J. S. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1656-4 · Cited by 241
Yang, K., Wang, X., Zhang, H., Wang, Z., Nan, G., Li, Y., Zhang, F., Mohammed, M. K., Haydon, R. C., Luu, H. H., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.144 · Cited by 241
Wnt signaling as a therapeutic target for bone diseases
Hoeppner, L. H., Secreto, F. J., & Westendorf, J. J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902841961 · Cited by 237
Characterization of the Structural Features and Interactions of Sclerostin
Veverka, V., Henry, A. J., Slocombe, P. M., Ventom, A., Mulloy, B., Muskett, F. W., Muzylak, M., Greenslade, K., Moore, A., Zhang, L., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807994200 · Cited by 233
Deregowski, V., Gazzerro, E., Priest, L., Rydziel, S., & Canalis, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508370200 · Cited by 231
International Union of Basic and Clinical Pharmacology. LXXX. The Class Frizzled Receptors
Schulte, G. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002931 · Cited by 231
Parathyroid hormone signaling through low-density lipoprotein-related protein 6
Wan, M., Yang, C., Li, J., Wu, X., Yuan, H., Ma, H., He, X., Nie, S., Chang, C., & Cao, X. (2008) · Genes & Development · doi:10.1101/gad.1702708 · Cited by 231
Self-citationLi, X., Warmington, K. S., Niu, Q.-T., Asuncion, F. J., Barrero, M., Grisanti, M., Dwyer, D., Stouch, B., Thway, T. M., Stolina, M., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.182 · Cited by 231
ten Dijke, P., Krause, C., de Gorter, D. J. J., Löwik, C. W. G. M., & van Bezooijen, R. L. (2008) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.g.01183 · Cited by 224
LRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST
Semenov, M. V., & He, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609509200 · Cited by 222
Self-citationQin, K., Yu, M., Fan, J., Wang, H., Zhao, P., Zhao, G., Zeng, W., Chen, C., Wang, Y., Wang, A., et al. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.01.030 · Cited by 217
Catabolic and anabolic actions of parathyroid hormone on the skeleton.
da Silva, B. C., Costa, A. G., Cusano, N. E., Kousteni, S., & Bilezikian, J. P. (2011) · PubMed · doi:10.3275/7925 · Cited by 215
Ahn, Y., Sanderson, B. W., Klein, O. D., & Krumlauf, R. (2010) · Development · doi:10.1242/dev.054668 · Cited by 213
The Impact of Diabetes and Diabetes Medications on Bone Health
Gilbert, M. P., & Pratley, R. E. (2015) · Endocrine Reviews · doi:10.1210/er.2012-1042 · Cited by 209
Park, K.-H., Kang, J. W., Lee, E.-M., Kim, J. S., Rhee, Y. H., Kim, M., Jeong, S. J., Park, Y. G., & Hoon Kim, S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00875.x · Cited by 205
Crystal structures of the extracellular domain of LRP6 and its complex with DKK1
Cheng, Z., Biechele, T., Wei, Z., Morrone, S., Moon, R. T., Wang, L., & Xu, W. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2139 · Cited by 202
In Vivo Analysis of Wnt Signaling in Bone
Glass, D. A., & Karsenty, G. (2007) · Endocrinology · doi:10.1210/en.2006-1372 · Cited by 200
Kamiya, N., Kobayashi, T., Mochida, Y., Yu, P. B., Yamauchi, M., Kronenberg, H. M., & Mishina, Y. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090806 · Cited by 198
Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells
Soltanoff, C. S., Yang, S., Chen, W., & Li, Y.-P. (2009) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i1.10 · Cited by 197
Wnt Signaling in Bone Development and Disease: Making Stronger Bone with Wnts
Regard, J. B., Zhong, Z., Williams, B. O., & Yang, Y. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007997 · Cited by 197
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis
Chan, B. Y., Fuller, E. S., Russell, A. K., Smith, S. M., Smith, M. M., Jackson, M. T., Cake, M. A., Read, R. A., Bateman, J. F., Sambrook, P. N., et al. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.04.014 · Cited by 197
Effects of PTH on osteocyte function
Bellido, T., Saini, V., & Pajevic, P. D. (2013) · Bone · doi:10.1016/j.bone.2012.09.016 · Cited by 196
Regulation of Lrp6 phosphorylation
Niehrs, C., & Shen, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0329-3 · Cited by 193
Determinants of serum sclerostin in healthy pre- and postmenopausal women
Ardawi, M.-S. M., Al-Kadi, H. A., Rouzi, A. A., & Qari, M. H. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.479 · Cited by 193
Zhu, X., Bai, W., & Zheng, H. (2021) · Bone Research · doi:10.1038/s41413-021-00143-3 · Cited by 192
Yu, Y., Wang, L., Ni, S., Li, D., Liu, J., Chu, H. Y., Zhang, N., Sun, M., Li, N., Ren, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31997-8 · Cited by 192
Villareal, D. T., Fontana, L., Das, S. K., Redman, L., Smith, S. R., Saltzman, E., Bales, C., Rochon, J., Pieper, C., Huang, M., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2701 · Cited by 191
“One such factor is sclerostin, a protein secreted by osteocytes in states of unloading (eg, weight loss) to inhibit Wnt/b-catenin signaling and bone formation.((39,40)) A recent study reported increase in sclerostin with weight loss that was prevented by exercise.”
BackgroundRoles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair
Macsai, C. E., Foster, B. K., & Xian, C. J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21342 · Cited by 187
Multiple myeloma in the marrow: pathogenesis and treatments
Fairfield, H., Falank, C., Avery, L., & Reagan, M. R. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13038 · Cited by 183
Metadata
- Authors
- Semënov, M., Tamai, K., & He, X.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- He, Xi
- ORCID
- He, Xi
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 280
- Issue
- 29
- Pages
- 26770-26775
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002725330
- Cited by
- 771
- References
- 42
- Citations by year
- 2026: 20 · 2025: 9 · 2024: 22 · 2023: 32 · 2022: 32 · 2021: 36 · 2020: 42 · 2019: 29 · 2018: 34 · 2017: 44 · 2016: 50 · 2015: 53 · 2014: 51 · 2013: 51 · 2012: 50
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5555 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- W. M. Keck Foundation
- Uehara Memorial Foundation
- National Institutes of Health
- National Institute of General Medical Sciences (GM057603)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- sclerostin, sclerosteosis, LRP5, LRP6, Wnt signaling, ligand binding, bone overgrowth, high bone mass, gain-of-function mutations, Xenopus embryo
- MeSH terms
- Animals, Bone Diseases, Developmental, Cell Line, Embryo, Mammalian, Embryo, Nonmammalian, Genetic Markers, Humans, Ligands, Protein Binding, Proteins, Receptors, LDL, Transfection, Xenopus, Signal Transduction, Bone Morphogenetic Proteins, Body Patterning, LDL-Receptor Related Proteins, Intercellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Wnt Proteins, Frizzled Receptors, Low Density Lipoprotein Receptor-Related Protein-6, Low Density Lipoprotein Receptor-Related Protein-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.